Natalie Kuldell
Natalie Kuldell is the founder and director of BioBuilder, an educational nonprofit dedicated to teaching synthetic biology. We spoke with...
Natalie Kuldell is the founder and director of BioBuilder, an educational nonprofit dedicated to teaching synthetic biology. We spoke with...
"We have a saying in Spain: 'Look at the sky with your feet on the ground'. This saying was always...
If you had the resources to start a biotech company and take on any problem, what would you choose? How...
Michael Schrader is co-founder and CEO of Vaxess Technologies, an innovative Cambridge-based company revolutionizing vaccine stabilization and delivery through the...
Synapse spoke with XTuit Pharmaceuticals Chief Scientific Officer Peter Blume-Jensen, MD, PhD, about the company's development of novel microenvironment-activated therapeutics...
Synapse spoke with John Gill, PhD, the Director of Research at Audion Therapeutics in Kendall Square about the company's drug...
Synapse gathers the main information to build an efficient overview of the incubators & accelerators of the biotech industry.
Quickly find the companies you know and explore their profiles.
Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI.
Synapse: the MIT Biotech Report is a publication of the MIT Biotech Group.
Accessibility
Website made with ⚗ by Norman Wozniak